质氨酸和肝素相互作用:叙述性审查
Martina Crivellari1, Giovanni Landoni1,2, Jacopo D'Andria Ursoleo1
1IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Annals of cardiac anaesthesia
|July 4, 2024
概括
蛋白质胺可以中和肝素.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质氨酸是肝素抗凝剂作用的关键解药.
- 肝素-抗素III (AT III) 复合体的形成促进了血液的流动性.
研究的目的:
- 审查原胺与肝素的相互作用及其抗凝固特性.
- 讨论前胺对未分离和低分子量肝素的疗效.
- 为了突出对protamine的潜在不良反应.
主要方法:
- 文献综述侧重于蛋白胺-氨酸相互作用.
- 对蛋白质胺对凝血因子和血小板功能影响的分析.
- 对不同类型的肝素对抗蛋白质胺的对抗性活性的检查.
主要成果:
- 质氨酸将肝素-AT III复合物解离,形成一个不活跃的复合物.
- 质氨酸表现出剂量依赖的抗凝剂特性,影响凝血和血小板.
- 质氨酸对抗未分离氨酸 (UFH) 和低分子量氨酸 (LMWH).
结论:
- 质氨酸是一种有效的肝素抗剂,具有复杂的剂量依赖作用.
- 了解前胺素的相互作用对于管理肝素治疗至关重要.
- 意识和早期管理与蛋白质胺相关的过敏反应至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
Factors Affecting Protein-Drug Binding: Drug Interactions
130
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
130
Depolarizing Blockers: Pharmocokinetics
317
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
317
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K


